RPTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Repare Therapeutics (RPTX) Earnings Date & Reports

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RPTX is expected to report earnings to fall 6.34% to -62 cents per share on May 13

Repare Therapeutics RPTX Stock Earnings Reports

Q1'25

Est.

$-0.63

Q4'24

Beat

by $0.14

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.28

The last earnings report on March 03 showed earnings per share of -67 cents, beating the estimate of -81 cents. With 312.08K shares outstanding, the current market capitalization sits at 45.49M.

View a ticker or compare two or three

Compare

RPTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RPTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7210 Frederick-Banting Street

Phone

+1 857 412-7018

Employees

179

Web

https://www.reparerx.com